Guided Therapeutics (GTHP) Interest Coverage Ratio (2010 - 2025)
Guided Therapeutics recorded quarterly Interest Coverage Ratio of 3.86 in Q4 2025, down 2.63% quarter-over-quarter from 3.76 in Q3 2025, and up 3.17% year-over-year from 3.74 in Q4 2024.
Guided Therapeutics' Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 3.86 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 3.17% year-over-year to 3.86; the TTM figure through Dec 2025 stood at 3.84 (up 30.55% YoY), while the FY2025 annual figure was 3.84, up 30.52% from the prior year.
- Interest Coverage Ratio came in at 3.86 for Q4 2025 at Guided Therapeutics, down from 3.76 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.82 in Q3 2021 to a low of 21.81 in Q2 2023.
- A 5-year average of 6.52 and a median of 5.03 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 863.18% in 2022 and soared 59.96% in 2024, its largest moves.
- Guided Therapeutics' Interest Coverage Ratio stood at 4.35 in 2021, then sank by 211.33% to 13.54 in 2022, then surged by 50.26% to 6.74 in 2023, then jumped by 40.84% to 3.99 in 2024, then climbed by 3.17% to 3.86 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 3.86, 3.76, and 4.86 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.98 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -3.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.86 |
| Sep 30, 2025 | -3.76 |
| Jun 30, 2025 | -4.86 |
| Mar 31, 2025 | -2.82 |
| Dec 31, 2024 | -3.99 |
| Sep 30, 2024 | -5.19 |
| Jun 30, 2024 | -8.73 |
| Mar 31, 2024 | -5.61 |
| Dec 31, 2023 | -6.74 |
| Sep 30, 2023 | -8.77 |
| Jun 30, 2023 | -21.81 |
| Mar 31, 2023 | -12.77 |
| Dec 31, 2022 | -13.54 |
| Sep 30, 2022 | -7.90 |
| Jun 30, 2022 | -2.80 |
| Mar 31, 2022 | -4.39 |
| Dec 31, 2021 | -4.35 |
| Sep 30, 2021 | -0.82 |
| Jun 30, 2021 | -1.78 |
| Mar 31, 2021 | -5.84 |
| Dec 31, 2020 | -1.97 |
| Sep 30, 2020 | -0.48 |
| Jun 30, 2020 | -1.20 |
| Mar 31, 2020 | -0.84 |
| Dec 31, 2019 | -0.41 |
| Sep 30, 2019 | -0.50 |
| Jun 30, 2019 | -1.24 |
| Mar 31, 2019 | -0.69 |
| Dec 31, 2018 | -0.46 |
| Sep 30, 2018 | -0.98 |
| Jun 30, 2018 | -1.66 |
| Mar 31, 2018 | -1.54 |
| Dec 31, 2017 | -2.50 |
| Sep 30, 2017 | -5.00 |
| Jun 30, 2017 | -1.64 |
| Mar 31, 2017 | -2.30 |
| Dec 31, 2016 | -3.74 |
| Sep 30, 2016 | -3.00 |
| Jun 30, 2016 | -0.74 |
| Mar 31, 2016 | -7.15 |
| Dec 31, 2015 | -20.05 |
| Sep 30, 2015 | -4.55 |
| Jun 30, 2015 | -4.96 |
| Mar 31, 2015 | -3.02 |
| Dec 31, 2014 | -4.02 |
| Sep 30, 2014 | -6.51 |
| Jun 30, 2014 | -43.13 |
| Mar 31, 2014 | -77.00 |
| Dec 31, 2013 | -135.00 |
| Sep 30, 2013 | -149.09 |
| Jun 30, 2013 | -193.44 |
| Mar 31, 2013 | -125.00 |
| Dec 31, 2012 | -58.35 |
| Sep 30, 2012 | -60.63 |
| Jun 30, 2012 | -60.42 |
| Mar 31, 2012 | -58.59 |
| Dec 31, 2011 | -160.11 |
| Sep 30, 2011 | -126.14 |
| Jun 30, 2011 | -26.94 |
| Mar 31, 2011 | -32.17 |
| Jun 30, 2010 | 18.96 |